A Chronic Obstructive Pulmonary Disease Exacerbation Following the Administration of a COVID 19-Booster Vaccine: A Case Report. 

 -  2022 
<br/><br/> We present a case of a patient who presented to the emergency department with symptoms suggestive of a chronic obstructive pulmonary disease (COPD) exacerbation one day after receiving the BNT162b2 COVID-19 booster vaccine. Laboratory studies indicated she was in a state of inflammation, but not infection. Other potential triggers, including cardiac and viral etiologies, were ruled out. To our knowledge, this is the first documented case of a COPD exacerbation following the administration of the BNT162b2 COVID-19 vaccine. Copyright © 2022 Greater Baltimore Medical Center. 
<br/><br/><br/>English 
<br/><br/><label>ISSN: </label>2000-9666 
<br/><br/><label>Standard No.: </label>10.55729/2000-9666.1107 [doi] jchim-12-05-110 [pii] PMC9529658 [pmc] 
<br/><br/><label>Subjects--Topical Terms: </label><br/>IN PROCESS -- NOT YET INDEXED
<br/><br/><label>Subjects--Geographic Terms: </label><br/>MedStar Franklin Square Medical Center
<br/><br/><label>Index Terms--Function: </label><br/>Case Reports